Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (131-140 of 272) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidenceGennaro Daniele, Pasqualina Giordano, Antonella De Luca, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Jean-Yves Douillard, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancerMassimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panelCesare Gridelli, Matti S Aapro, Sandro Barni, et al.
Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.
Journal of Translational Medicine|May 16, 2025
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatmentsMaria Lucia Iacovino, Simone Talucci, Laura Arenare, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
Pageof 28

Showing results (131-140 of 272) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidenceGennaro Daniele, Pasqualina Giordano, Antonella De Luca, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Andrea Ardizzoni, Jean-Yves Douillard, et al.
Sarcoma|March 29, 2016
Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced AngiosarcomaGaetano Apice, Antonio Pizzolorusso, Massimo Di Maio, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancerMassimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panelCesare Gridelli, Matti S Aapro, Sandro Barni, et al.
Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.
Journal of Translational Medicine|May 16, 2025
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatmentsMaria Lucia Iacovino, Simone Talucci, Laura Arenare, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
JAMA Oncology|February 9, 2023
Cancer in Transgender and Gender-Diverse Persons: A ReviewAlberto Giovanni Leone, Dario Trapani, Matthew B Schabath, et al.
Pageof 28